Molecular Biology

This EMBO workshop brings experimental and computational researchers together around molecular mechanisms of adaptation, evolutionary dynamics, microbial communities, symbiosis, biodiversity, and cell-environment interactions.

Tom Nowakowski explains lineage barcoding and single-cell sequencing approaches for reconstructing neural stem-cell family trees and early wiring programs in developing mouse and human brains.

This EMBO Workshop connects organelle contact sites and cytoskeletal interactions with metabolism, signalling, and trafficking, and examines their relevance to neurodegeneration, cancer, and other diseases.

This EMBO and EMBL symposium convenes leaders, postdoctoral researchers, and students to discuss current RNA biology. The programme spans transcription, RNA processing and modification, messenger-RNA export and localisation, RNA surveillance and decay, translation, non-coding RNAs, gene-expression control, and coupling among these processes.

Marcus Buggert’s group at the Centre for Infectious Medicine develops mRNA-based, CD19-directed CAR T cells for chronic lymphocytic leukaemia. The project uses electroporation and targeted lipid nanoparticles to generate transient CAR expression and examines how disease stage, treatment and T-cell differentiation affect killing of malignant B cells. Work combines primary human cells and patient samples, functional co-cultures, high-parameter flow cytometry and live-cell imaging to study killing kinetics, serial killing and repeated mRNA delivery. Phenotypic, transcriptional and epigenetic analyses will identify mechanisms limiting cytotoxicity and routes to improve receptor availability and function. This full-time postdoctoral appointment is based in Flemingsberg; applications through Varbi close on 6 October 2026.

EMBL offers support for external independent scientists to spend three to six months at one of its six sites, working with an EMBL group or team leader. The scheme supports scientific exchange and transfer of expertise across molecular biology and related research. Awards reimburse eligible additional costs, up to EUR 15,000. Applicants may be based anywhere, but must retain employment and salary from their home institution. The host submits the jointly prepared application through the linked Workday opportunity. This round opened on 1 September and closes on 9 October 2026.

Two faculty appointments in the Laboratory of Phytopathology will develop new approaches to plant–pathogen interactions, disease resilience and pathogen adaptation. Relevant directions include theoretical phytopathology, predictive modelling, quantitative immunity and structural biology. The roles combine research funding, teaching, supervision, collaboration and staff mentoring within the university’s Professor Career Paths framework. Apply online by 10 October inclusive; applications are reviewed regularly and posts may fill earlier.

Study the transition from normal blood stem cells to leukaemic stem cells and identify mechanisms that enable disease progression and therapeutic evasion. The project uses patient material and experimental approaches in cell and molecular biology, with opportunities to integrate omics and functional perturbation. This full-time temporary post is in Petter Woll’s research group. Apply by 11 October 2026.

Marcus Buggert’s group at the Centre for Infectious Medicine develops mRNA-based, CD19-directed CAR T cells for chronic lymphocytic leukaemia. The project uses electroporation and targeted lipid nanoparticles to generate transient CAR expression and examines how disease stage, treatment and T-cell differentiation affect killing of malignant B cells. Work combines primary human cells and patient samples, functional co-cultures, high-parameter flow cytometry and live-cell imaging to study killing kinetics, serial killing and repeated mRNA delivery. Phenotypic, transcriptional and epigenetic analyses will identify mechanisms limiting cytotoxicity and routes to improve receptor availability and function. This full-time postdoctoral appointment is based in Flemingsberg; applications through Varbi close on 6 October 2026.

Study the transition from normal blood stem cells to leukaemic stem cells and identify mechanisms that enable disease progression and therapeutic evasion. The project uses patient material and experimental approaches in cell and molecular biology, with opportunities to integrate omics and functional perturbation. This full-time temporary post is in Petter Woll’s research group. Apply by 11 October 2026.

Investigate extracellular vesicles, inter-tissue communication and insulin resistance in type 2 diabetes within the integrative physiology environment. Combine cellular and molecular experiments with omics approaches to understand mechanisms of metabolic regulation. This full-time research specialist position covers an approximately one-year leave period. Apply through the university recruitment portal by 15 October 2026.

Support recruitment or retention of outstanding established biomedical investigators in Denmark. Funding of up to DKK 60 million over seven years enables an ambitious research programme and collaboration across disciplines or countries. Applicants must have led an independent programme for at least seven years and commit at least 75% of a full-time position to the Danish host. The first-stage application, including host support, is due 27 October 2026 at 2 p.m. Copenhagen time. The February 2027 full-proposal stage is by invitation.